172 related articles for article (PubMed ID: 14751769)
1. Neuronal localization of C1q in preclinical Alzheimer's disease.
Fonseca MI; Kawas CH; Troncoso JC; Tenner AJ
Neurobiol Dis; 2004 Feb; 15(1):40-6. PubMed ID: 14751769
[TBL] [Abstract][Full Text] [Related]
2. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
[TBL] [Abstract][Full Text] [Related]
3. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.
Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA
Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype.
Minter MR; Moore Z; Zhang M; Brody KM; Jones NC; Shultz SR; Taylor JM; Crack PJ
Acta Neuropathol Commun; 2016 Jul; 4(1):72. PubMed ID: 27400725
[TBL] [Abstract][Full Text] [Related]
5. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease.
Fonseca MI; Zhou J; Botto M; Tenner AJ
J Neurosci; 2004 Jul; 24(29):6457-65. PubMed ID: 15269255
[TBL] [Abstract][Full Text] [Related]
6. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
7. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.
Zhou J; Fonseca MI; Pisalyaput K; Tenner AJ
J Neurochem; 2008 Sep; 106(5):2080-92. PubMed ID: 18624920
[TBL] [Abstract][Full Text] [Related]
8. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.
Gyure KA; Durham R; Stewart WF; Smialek JE; Troncoso JC
Arch Pathol Lab Med; 2001 Apr; 125(4):489-92. PubMed ID: 11260621
[TBL] [Abstract][Full Text] [Related]
9. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.
Wirths O; Multhaup G; Czech C; Blanchard V; Moussaoui S; Tremp G; Pradier L; Beyreuther K; Bayer TA
Neurosci Lett; 2001 Jun; 306(1-2):116-20. PubMed ID: 11403971
[TBL] [Abstract][Full Text] [Related]
10. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
Dickson TC; Vickers JC
Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
[TBL] [Abstract][Full Text] [Related]
11. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
Nunomura A; Perry G; Hirai K; Aliev G; Takeda A; Chiba S; Smith MA
Ann N Y Acad Sci; 1999; 893():362-4. PubMed ID: 10672267
[No Abstract] [Full Text] [Related]
12. Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease.
Sly LM; Krzesicki RF; Brashler JR; Buhl AE; McKinley DD; Carter DB; Chin JE
Brain Res Bull; 2001 Dec; 56(6):581-8. PubMed ID: 11786245
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains.
Nagele RG; D'Andrea MR; Lee H; Venkataraman V; Wang HY
Brain Res; 2003 May; 971(2):197-209. PubMed ID: 12706236
[TBL] [Abstract][Full Text] [Related]
14. A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain.
Sarsoza F; Saing T; Kayed R; Dahlin R; Dick M; Broadwater-Hollifield C; Mobley S; Lott I; Doran E; Gillen D; Anderson-Bergman C; Cribbs DH; Glabe C; Head E
Acta Neuropathol; 2009 Oct; 118(4):505-17. PubMed ID: 19360426
[TBL] [Abstract][Full Text] [Related]
15. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
16. Localization and cell association of C1q in Alzheimer's disease brain.
Afagh A; Cummings BJ; Cribbs DH; Cotman CW; Tenner AJ
Exp Neurol; 1996 Mar; 138(1):22-32. PubMed ID: 8593893
[TBL] [Abstract][Full Text] [Related]
17. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA
Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821
[TBL] [Abstract][Full Text] [Related]
18. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue.
Martins RN; Taddei K; Kendall C; Evin G; Bates KA; Harvey AR
Neuroscience; 2001; 106(3):557-69. PubMed ID: 11591456
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.
Bergamaschini L; Canziani S; Bottasso B; Cugno M; Braidotti P; Agostoni A
Clin Exp Immunol; 1999 Mar; 115(3):526-33. PubMed ID: 10193429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
